Results 21 to 30 of about 1,554,916 (325)

COVID‐19: vaccine’s progress [PDF]

Microbial Biotechnology, 2021
Summary Under the pressure of the COVID‐19 pandemic, vaccines were developed and rolled out into mass vaccination campaigns at incredible speed. What normally takes a decade was worked out within a year. Vaccines were produced along many different platforms ranging from inactivated whole virus vaccines over adenovirus‐vectored ...
openaire   +4 more sources

COVID-19 vaccination passports [PDF]

Science, 2021
As countries grow eager to reignite their economies and people increasingly yearn for mobility and normalcy in life, pressure is mounting for some form of COVID-19 health status certificate that would support these desires. There has already been an explosion of COVID-19 passport initiatives for domestic use and international travel.
Dye, C, Mills, MC
openaire   +2 more sources

Covid 19 Vaccine - boon or a bane? [PDF]

Perspectives In Medical Research, 2020
The global struggle against corona virus disease 2019(COVID19) is now in its 8th month since the pandemic virus SARS –COV2 has first emerged.The severe economic,personal and psychological adverse effects of shutdowns and social distancing make these ...
Kasturi Ravinder Reddy1 , Samkisha Earna2
doaj   +1 more source

Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine through 6 Months

New England Journal of Medicine, 2021
Background BNT162b2 is a lipid nanoparticle–formulated, nucleoside-modified RNA vaccine encoding a prefusion-stabilized, membrane-anchored severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) full-length spike protein.
Stephen J. Thomas, E. Moreira, N. Kitchin, J. Absalon, A. Gurtman, S. Lockhart, John L. Perez, Gonzalo Pérez Marc, F. Polack, C. Zerbini, R. Bailey, K. Swanson, Xia Xu, Satrajit Roychoudhury, K. Koury, S. Bouguermouh, W. Kalina, David Cooper, R. Frenck, L. Hammitt, Ö. Türeci, H. Nell, A. Schaefer, S. Ünal, Qi Yang, P. Liberator, D. Tresnan, Susan H. Mather, P. Dormitzer, U. Şahin, W. Gruber, K. Jansen   +31 more
semanticscholar   +1 more source

Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine

New England Journal of Medicine, 2020
Background Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection and the resulting coronavirus disease 2019 (Covid-19) have afflicted tens of millions of people in a worldwide pandemic.
F. Polack, Stephen J. Thomas, N. Kitchin, J. Absalon, A. Gurtman, S. Lockhart, John L. Perez, Gonzalo Pérez Marc, E. Moreira, C. Zerbini, R. Bailey, K. Swanson, Satrajit Roychoudhury, K. Koury, Ping Li, W. Kalina, David Cooper, R. Frenck, L. Hammitt, Ö. Türeci, H. Nell, A. Schaefer, S. Ünal, D. Tresnan, Susan H. Mather, P. Dormitzer, U. Şahin, K. Jansen, W. Gruber   +28 more
semanticscholar   +1 more source

Safety of the BNT162b2 mRNA Covid-19 Vaccine in a Nationwide Setting

New England Journal of Medicine, 2021
Background Preapproval trials showed that messenger RNA (mRNA)–based vaccines against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) had a good safety profile, yet these trials were subject to size and patient-mix limitations. An evaluation
Noam Barda, Noa Dagan, Y. Ben-Shlomo, Eldad Kepten, Jacob G Waxman, Reut Ohana, M. Hernán, M. Lipsitch, I. Kohane, D. Netzer, Ben Y. Reis, R. Balicer   +11 more
semanticscholar   +1 more source

Waning Immune Humoral Response to BNT162b2 Covid-19 Vaccine over 6 Months

New England Journal of Medicine, 2021
Background Despite high vaccine coverage and effectiveness, the incidence of symptomatic infection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has been increasing in Israel.
Einav G. Levin, Y. Lustig, Carmit Cohen, R. Fluss, V. Indenbaum, S. Amit, R. Doolman, K. Asraf, E. Mendelson, A. Ziv, Carmit Rubin, L. Freedman, Y. Kreiss, G. Regev-Yochay   +13 more
semanticscholar   +1 more source

COVID-19 vaccines and vaccine administration [PDF]

British Journal of Nursing, 2021
This article provides an overview of current COVID-19 vaccines available within the UK, including their mode of action, storage and handling. It outlines the recommendations on priority groups for vaccination and provides insight into the training recommendations for vaccinators.
Gordon, Charlotte, Porteous, Debbie, Unsworth, John   +2 more
openaire   +2 more sources

Facilitators and barriers to COVID-19 vaccination among incarcerated people and staff in three large, state prisons: a cross-sectional study

Health & Justice, 2023
Background The COVID-19 pandemic has disproportionately impacted individuals in carceral facilities – both incarcerated people and staff. Vaccination is an important tool in reducing the risk of COVID-19 infection, hospitalization, and death.
Ingie Osman, Antonio Williams, Katie Pierson, Eric Ryu, Rebecca J. Shlafer   +4 more
doaj   +1 more source

COVID‐19 vaccine‐associated organizing pneumonia

Respirology Case Reports, 2022
We report the first case of organizing pneumonia (OP) associated with a new coronavirus disease (COVID‐19) vaccination. A 78‐year‐old woman developed cough and dyspnoea 10 days after receiving BNT162b2.
Tomohiro Yoshikawa, Katsuyoshi Tomomatsu, Eriko Okazaki, Tomoe Takeuchi, Yukihiro Horio, Yusuke Kondo, Tsuyoshi Oguma, Koichiro Asano   +7 more
doaj   +1 more source